Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 808-815, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Planella, T.
Right arrow Articles by Ordóñez-Llanos, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Planella, T.
Right arrow Articles by Ordóñez-Llanos, J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 1997;43:808-815.)
© 1997 American Association for Clinical Chemistry, Inc.


Articles

Calculation of LDL-cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia

Teresa Planella1,a, Mariano Cortés1, Cecília Martínez-Brú1, Francesc González-Sastre1,2 and Jordi Ordóñez-Llanos1,2

1 Servei de Bioquímica and
2 Departament de Bioquímica i Biologia Molecular, Hospital Santa Creu i Sant Pau, Universitat Autònoma, Barcelona, Spain.
a Address correspondence to this author at: Servei de Bioquímica, Hospital Santa Creu i Sant Pau, Avinguda Sant Antoni Ma Claret 167, 08025-Barcelona, Spain. Fax +34-3-2919196.

In this paper we propose a calculation of LDL-cholesterol (LDL-C) not affected by hypertriglyceridemia by using lipid quantities directly measured in total serum. We also propose an algorithm for the classification of nonchylomicronemic dyslipemias. Plasma apolipoproteins (apo) A-I, B, total cholesterol (TC), triglycerides (TG), and cholesterol of lipoproteins were measured in a group of 38 normolipemic and 120 dyslipemic patients (42 phenotype IIa, 38 IIb, and 40 IV) classified according to TG and LDL-C values. Discriminant analysis was applied to obtain the best classification with the lowest number of quantities directly measured from total serum (TC, TG, and apo B), and multiple regression analysis was performed to find an equation to calculate LDL-C from these quantities. Apo B seems to be a useful discriminator between normolipemic and phenotype IIa patients, by using a cutoff value of 1.35 g/L obtained by ROC curve analysis. The proposed algorithm, based on lipid quantities measured by easily automated methods, is shown to be a good alternative for the classification of nonhyperchylomicronemic dyslipemia. LDL-C calculated from TC, TG, and apo B proved a better estimate of true LDL-C than the estimate obtained with Friedewald's formula.


Key Words: indexing terms: apolipoproteins • Friedewald formula • HDL-cholesterol • triglycerides • VLDL-cholesterol • discriminant analysis • multiple regression




The following articles in journals at HighWire Press have cited this article:


Home page
J CARDIOVASC PHARMACOL THERHome page
E. T. Bairaktari, K. I. Seferiadis, and M. S. Elisaf
Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 45 - 54.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
M. Nauck, G. R. Warnick, and N. Rifai
Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation
Clin. Chem., February 1, 2002; 48(2): 236 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Bonnet, J.-B. Ruidavets, J. Tuech, J. FerriÈres, X. Collet, J. Fauvel, P. Massip, and B. Perret
Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of Lipodystrophy
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 296 - 302.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
A. M. Wagner, J. L. Sanchez-Quesada, A. Perez, M. Rigla, M. Cortes, F. Blanco-Vaca, and J. Ordonez-Llanos
Inaccuracy of Calculated LDL-Cholesterol in Type 2 Diabetes: Consequences for Patient Risk Classification and Therapeutic Decisions
Clin. Chem., November 1, 2000; 46(11): 1830 - 1832.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.